Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT02693275 Completed - Healthy Volunteers Clinical Trials

Reference Database Development for the Quotient® System iPad Test

Start date: April 2016
Phase: N/A
Study type: Interventional

This study is being conducted to create a database for the Quotient® System iPad Test. Using community sampling, NCS Pearson will compile the results of this study to create a database against which the results of clinical Quotient tests may be compared to determine patient performance relative to the expected results for developmental age and gender.

NCT ID: NCT02685124 Completed - Healthy Volunteers Clinical Trials

Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans (METABORANGE).

METABORANGE
Start date: September 2015
Phase: Phase 0
Study type: Interventional

This study evaluates the effect of intake of two orange juice varieties in healthy adults. The participants will receive "Bahia" orange juice, "Cara-Cara" orange juice or a isocaloric control drink in a cross-over study.

NCT ID: NCT02684630 Completed - Healthy Volunteers Clinical Trials

Trima Accel® System Post Count Algorithm Study

Start date: January 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to optimize collected platelet yields in single and double platelet collections, while maintaining donor postplatelet count of >100,000/µL.

NCT ID: NCT02684396 Completed - Healthy Volunteers Clinical Trials

Phase 1, TAK-648, Single-Rising Dose Study

Start date: September 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the safety, tolerability and pharmacokinetics of TAK-648 when administered as a single oral dose of TAK-648 solution at escalating dose levels in healthy participants.

NCT ID: NCT02683083 Completed - Breast Cancer Clinical Trials

Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients

CAM-VHH1
Start date: October 2016
Phase: Phase 1
Study type: Interventional

Primary purpose of the clinical study is to evaluate the safety, biodistribution and radiation dosimetry of [131I]-SGMIB Anti-HER2 VHH1 in healthy volunteers and patients with HER2+ breast cancer. Secondary purpose of the clinical study is to evaluate the tumor uptake of [131I]-SGMIB Anti-HER2 VHH1 in patients with HER2+ breast cancer.

NCT ID: NCT02678988 Completed - Healthy Volunteer Clinical Trials

A Study to Evaluate the Bioequivalence of Tocilizumab Following Subcutaneous Administration Via an Autoinjector (AI 1000-G2) Versus a Pre-Filled Syringe in Healthy Volunteers

Start date: February 2016
Phase: Phase 1
Study type: Interventional

The study consists of an eligibility screening period, two study periods involving single doses of tocilizumab (TCZ) according to an open-label, randomized, two-period crossover design with an interval of 6 weeks between periods, and a 6 week follow-up period. Healthy participants will receive a single subcutaneous (SC) injection of TCZ via a pre-filled syringe-needle safety device (PFS-NSD) and a single injection via an autoinjector (AI). The total duration of the study is up to 16 weeks from screening to follow-up. After screening, eligible participants will be randomly assigned to one of the two possible treatment sequences (Sequence 1: AI-1000 G2 followed by PFS-NSD or Sequence 2: PFS-NSD followed by AI-1000 G2) and assigned to one of three injection sites (1: abdomen, 2: thigh, or 3: upper arm). All participant groups will receive a total of two TCZ administrations each.

NCT ID: NCT02671097 Completed - Healthy Volunteers Clinical Trials

Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate

Start date: February 2016
Phase: Phase 1
Study type: Interventional

Evaluation of the potential perpetrator effect of BAY1841788 (ODM-201) on rosuvastatin pharmacokinetics. PK of BAY1841788 (ODM-201) after single and repeated administration in male and female subjects.

NCT ID: NCT02669121 Completed - Healthy Volunteers Clinical Trials

Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults

Start date: June 14, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of the Norovirus (NoV) GI.1/GII.4 bivalent virus-like particle vaccine against moderate or severe acute gastroenteritis (AGE) due to genotype-specific (GI.1 and GII.4) NoV strains.

NCT ID: NCT02668367 Completed - Healthy Volunteers Clinical Trials

Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

Start date: November 2015
Phase: Phase 1
Study type: Interventional

This is a single center, sequential-cohort, double-blind, placebo-controlled, multiple ascending dose (MAD), 7-day treatment period study in healthy subjects.

NCT ID: NCT02665637 Completed - Healthy Volunteers Clinical Trials

Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin

Start date: December 2015
Phase: Phase 1
Study type: Interventional

This is a double-blind, two-arm, parallel-group, single-dose study.